Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Transplant Cell Ther. 2022 Dec 27;29(3):208.e1–208.e6. doi: 10.1016/j.jtct.2022.12.017

Figure 1:

Figure 1:

Figure 1:

a. 3-year overall survival by conditioning intensity, b. 3-year non-relapse mortality by conditioning intensity. RIC: reduced intensity conditioning, MAC: Myeloablative conditioning